— Know what they know.
Not Investment Advice

SXTP NASDAQ

60 Degrees Pharmaceuticals, Inc.
1W: +18.8% 1M: +46.4% 3M: -17.3% YTD: -32.5% 1Y: -5.4% 3Y: -97.0%
$1.39
+0.14 (+11.20%)
 
Weekly Expected Move ±12.4%
$1 $1 $1 $2 $2
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 63 · $4.9M mcap · 2M float · 4.03% daily turnover · Short 38% of daily vol

Balance Sheet Trends

Total Assets
$5M -6.8% ▼
5Y CAGR: +15.5%
Total Liabilities
$144K -92.0% ▼
5Y CAGR: -63.0%
Shareholders Equity
$3M -16.3% ▼
Cash & Investments
$3M -18.8% ▼
5Y CAGR: +70.4%
Total Debt
$0 -100.0% ▼
Net Debt
-$2M -0.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$115K$265K$2M$2M$2M
Short-Term Investments$0$0$0$2M$1M
Cash & ST Investments$115K$265K$2M$3M$3M
Net Receivables$146K$46K$231K$487K$510K
Inventory$689K$519K$466K$443K$657K
Other Current Assets$0$69K$3M$1M$978K
Total Current Assets$1M$1M$7M$5M$5M
Property, Plant & Equip.$108K$34K$71K$150K$246K
Goodwill & Intangibles$109K$164K$227K$157K$224K
Long-Term Investments$0$0$0$0$0
Other Non-Current Assets$0$0$243K$66K$0
Total Non-Current Assets$217K$198K$541K$373K$471K
Total Assets$1M$1M$8M$6M$5M
— Liabilities —
Accounts Payable$589K$759K$506K$1M$0
Short-Term Debt$0$21M$9K$9K$0
Deferred Revenue$0$325K$0$0$0
Other Current Liabilities$0$1M$2M$641K$2M
Total Current Liabilities$635K$24M$3M$2M$2M
Long-Term Debt$19M$1M$150K$147K$0
Other Non-Current Liab.$0$0$0$0$0
Total Non-Current Liabilities$19M$2M$150K$147K$0
Total Liabilities$20M$25M$3M$2M$144K
— Equity —
Common Stock$5M$239$10$57$116
Retained Earnings-$23M-$29M-$33M-$41M-$48M
Accumulated OCI$76K$74K$136K$135K$143K
Total Stockholders Equity-$18M-$24M$5M$4M$3M
Total Liabilities & Equity$1M$1M$8M$6M$4M
— Key Metrics —
Total Debt$19M$22M$173K$156K$0
Net Debt$19M$22M-$2M-$2M-$2M
Total Investments$0$0$0$2M$1M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms